Log In
Print this Print this

Karenitecin (BNP1350)

  Manage Alerts
Collapse Summary General Information
Company BioNumerik Pharmaceuticals Inc.
DescriptionSilicon containing camptothecin chemotherapeutic
Molecular Target Topoisomerase I (TOP1)
Mechanism of ActionTopoisomerase I inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today